2,100
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Multipotent mesenchymal stromal cells are sensitive to thermic stress – potential implications for therapeutic hyperthermia

, , , , , , , , , & ORCID Icon show all
Pages 430-441 | Received 03 Mar 2020, Accepted 15 Apr 2020, Published online: 05 May 2020

References

  • Perez CA, Pajak T, Emami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol. 1991;14(2):133–141.
  • Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys. 1996;35(4):731–744.
  • Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11(6):561–570.
  • Datta NR, Puric E, Klingbiel D, et al. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2016;94(5):1073–1087.
  • Notter M, Thomsen AR, Nitsche M, et al. Combined wIRA-hyperthermia and hypofractionated re-irradiation in the treatment of locally recurrent breast cancer: evaluation of therapeutic outcome based on a novel size classification. Cancers. 2020;12(3):606.
  • Bicher HI, Hetzel FW, Sandhu TS, et al. Effects of hyperthermia on normal and tumor microenvironment. Radiology. 1980;137(2):523–530.
  • Vaupel P, Müller-Klieser W, Otte J, et al. Impact of various thermal doses on the oxygenation and blood flow in malignant tumors upon localized hyperthermia. In: Lübbers DW, Acker H, Leniger-Follert E, et al., editors. Oxygen transport to tissue-V. Boston, MA: Springer US; 1984. p. 621–629.
  • Song CW, Shakil A, Osborn JL, et al. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia. 1996;12(3):367–373.
  • Gray LH, Conger AD, Ebert M, et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953;26(312):638–648.
  • Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia. 2014;30(8):531–539.
  • Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279–4295.
  • Rzhaninova AA, Gornostaeva SN, Goldshtein DV. Isolation and phenotypical characterization of mesenchymal stem cells from human fetal thymus. Bull Exp Biol Med. 2005;139(1):134–140.
  • In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22(7):1338–1345.
  • Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625–634.
  • Friedenstein A, Chailakhjan R, Lalykina K. The development of fibroblast colonies in monolayer cultures of guinea‐pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403.
  • Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6(2):230–247.
  • Park H, Cho JA, Kim SK, et al. Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death. Int J Hyperthermia. 2008;24(8):638–648.
  • Cho JA, Park H, Kim HK, et al. Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer. 2009;115(2):311–323.
  • Lis R, Touboul C, Mirshahi P, et al. Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer. 2011;128(3):715–725.
  • Hesami S, Mohammadi M, Rezaee MA, et al. The effects of hyperthermia on the immunomodulatory properties of human umbilical cord vein mesenchymal stem cells (MSCs). Int J Hyperthermia. 2017;33(7):1–712.
  • Oldenborg S, Rasch CRN, van Os R, et al. Reirradiation + hyperthermia for recurrent breast cancer en cuirasse [Rebestrahlung + Hyperthermie bei Brustkrebs in Form von Cancer en cuirasse]. Strahlenther Onkol. 2018;194(3):206–214.
  • Sasaki M, Abe R, Fujita Y, et al. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180(4):2581–2587.
  • Landry Y, Le O, Mace KA, et al. Secretion of SDF-1alpha by bone marrow-derived stromal cells enhances skin wound healing of C57BL/6 mice exposed to ionizing radiation. J Cell Mol Med. 2010;14(6b):1594–1604.
  • Rühle A, Perez RL, Glowa C, et al. Cisplatin radiosensitizes radioresistant human mesenchymal stem cells. Oncotarget. 2017;8(50):87809–87820.
  • Notter M, Piazena H, Vaupel P. Hypofractionated re-irradiation of large-sized recurrent breast cancer with thermography-controlled, contact-free water-filtered infra-red-A hyperthermia: a retrospective study of 73 patients. Int J Hyperthermia. 2017;33(2):227–236.
  • Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317.
  • Lopez Perez R, Munz F, Kroschke J, et al. Cell cycle-specific measurement of γH2AX and apoptosis after genotoxic stress by flow cytometry. J Vis Exp. 2019;(151). DOI:10.3791/59968.
  • Trautinger F, Kokesch C, Herbacek I, et al. Overexpression of the small heat shock protein, hsp27, confers resistance to hyperthermia, but not to oxidative stress and UV-induced cell death, in a stably transfected squamous cell carcinoma cell line. J Photochem Photobiol B. 1997;39(1):90–95.
  • Xu M, Wright WD, Higashikubo R, et al. Intracellular distribution of hsp70 during long duration moderate hyperthermia. Int J Hyperthermia. 1998;14(2):211–225.
  • Shahar T, Rozovski U, Hess KR, et al. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro Oncol. 2017;19(5):660–668.
  • Krueger TE, Thorek DLJ, Meeker AK, et al. Tumor-infiltrating mesenchymal stem cells: drivers of the immunosuppressive tumor microenvironment in prostate cancer? Prostate. 2019;79(3):320–330.
  • Karnoub AE, Dash AB, Vo AP, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563.
  • Liotta F, Querci V, Mannelli G, et al. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br J Cancer. 2015;112(4):745–754.
  • Rühle A, Huber PE, Saffrich R, et al. The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy‐induced toxicity. Int J Cancer. 2018;143(11):2628–2639.
  • Rühle A, Perez RL, Zou B, et al. The therapeutic potential of mesenchymal stromal cells in the treatment of chemotherapy-induced tissue damage. Stem Cell Rev and Rep. 2019;15(3):356–373.
  • Oei A, Vriend L, Krawczyk P, et al. Targeting therapy-resistant cancer stem cells by hyperthermia. Int J Hyperthermia. 2017;33(4):419–427.
  • Deskins DL, Bastakoty D, Saraswati S, et al. Human mesenchymal stromal cells: identifying assays to predict potency for therapeutic selection. Stem Cells Transl Med. 2013;2(2):151–158.
  • Nakajima K, Yanagawa T, Watanabe H, et al. Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor. Oncol Rep. 2012;28(6):1953–1958.
  • Jin H, Zhao Y, Zhang S, et al. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Mol Med Rep. 2018;17(5):7274–7280.
  • Lee TH, Bu J, Kim BH, et al. Sub-lethal hyperthermia promotes epithelial-to-mesenchymal-like transition of breast cancer cells: implication of the synergy between hyperthermia and chemotherapy. RSC Adv. 2019;9(1):52–57.
  • Li L, Jiang J. Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med. 2011;5(1):33–39.
  • Munz F, Lopez Perez R, Trinh T, et al. Human mesenchymal stem cells lose their functional properties after paclitaxel treatment. Sci Rep. 2018;8(1):312.
  • Nicolay NH, Liang Y, Lopez Perez R, et al. Mesenchymal stem cells are resistant to carbon ion radiotherapy. Oncotarget. 2015;6(4):2076–2087.
  • Rühle A, Xia O, Perez RL, et al. The radiation resistance of human multipotent mesenchymal stromal cells is independent of their tissue of origin. Int J Radiat Oncol Biol Phys. 2018;100(5):1259–1269.
  • Lopez Perez R, Brauer J, Rühle A, et al. Human mesenchymal stem cells are resistant to UV-B irradiation. Sci Rep. 2019;9(1):20000.
  • Furusawa Y, Iizumi T, Fujiwara Y, et al. Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress. Apoptosis. 2012;17(1):102–112.
  • Roti Roti JL. Cellular responses to hyperthermia (40–46 °C): cell killing and molecular events. Int J Hyperthermia. 2008;24(1):3–15.
  • Sinclair W, Morton RA. Variations in X-ray response during the division cycle of partially synchronized Chinese hamster cells in culture. Nature. 1963;199(4899):1158–1160.
  • Lopez Perez R, Münz F, Vidoni D, et al. Mesenchymal stem cells preserve their stem cell traits after exposure to antimetabolite chemotherapy. Stem Cell Res. 2019;40:101536.
  • Nicolay NH, Lopez Perez R, Rühle A, et al. Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin. Sci Rep. 2016;6(1):2003.
  • Nicolay NH, Rühle A, Perez RL, et al. Mesenchymal stem cells exhibit resistance to topoisomerase inhibition. Cancer Lett. 2016;374(1):75–84.
  • Nicolay NH, Lopez Perez R, Saffrich R, et al. Radio-resistant mesenchymal stem cells: mechanisms of resistance and potential implications for the clinic. Oncotarget. 2015;6(23):19366–19380.
  • Harmon BV, Takano YS, Winterford CM, et al. The role of apoptosis in the response of cells and tumours to mild hyperthermia. Int J Radiat Biol. 1991;59(2):489–501.
  • Ahmed K, Tabuchi Y, Kondo T. Hyperthermia: an effective strategy to induce apoptosis in cancer cells. Apoptosis. 2015;20(11):1411–1419.
  • Sakaguchi Y, Stephens LC, Makino M, et al. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats. Cancer Res. 1995;55(22):5459–5464.
  • Alekseenko LL, Zemelko VI, Domnina AP, et al. Sublethal heat shock induces premature senescence rather than apoptosis in human mesenchymal stem cells. Cell Stress Chaperones. 2014;19(3):355–366.
  • Chen J, Shi ZD, Ji X, et al. Enhanced osteogenesis of human mesenchymal stem cells by periodic heat shock in self-assembling peptide hydrogel. Tissue Eng Part A. 2013;19(5–6):716–728.
  • Li C, Sunderic K, Nicoll SB, et al. Downregulation of heat shock protein 70 impairs osteogenic and chondrogenic differentiation in human mesenchymal stem cells. Sci Rep. 2018;8(1):553–553.
  • Chen E, Xue D, Zhang W, et al. Extracellular heat shock protein 70 promotes osteogenesis of human mesenchymal stem cells through activation of the ERK signaling pathway. FEBS Lett. 2015;589(24PartB):4088–4096.
  • Chen J, Li C, Wang S. Periodic heat shock accelerated the chondrogenic differentiation of human mesenchymal stem cells in pellet culture. PLoS One. 2014;9(3):e91561.
  • Seegenschmiedt MH, Klautke G, Walther E, et al. Water-filtered infrared-A-hyperthermia combined with radiotherapy in advanced and recurrent tumors. Initial results of a multicenter phase I-II study. Strahlenther Onkol. 1996;172(9):475–484.
  • Dokladny K, Myers OB, Moseley PL. Heat shock response and autophagy—cooperation and control. Autophagy. 2015;11(2):200–213.
  • Ravagnan L, Gurbuxani S, Susin SA, et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001;3(9):839–843.
  • Moloney TC, Hoban DB, Barry FP, et al. Kinetics of thermally induced heat shock protein 27 and 70 expression by bone marrow-derived mesenchymal stem cells. Protein Sci. 2012;21(6):904–909.
  • Wang Q, Li X, Wang Q, et al. Heat shock pretreatment improves mesenchymal stem cell viability by heat shock proteins and autophagy to prevent cisplatin-induced granulosa cell apoptosis. Stem Cell Res Ther. 2019;10(1):348.
  • Mahmoudi K, Bouras A, Bozec D, et al. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy and application in humans. Int J Hyperthermia. 2018;34(8):1316–1328.
  • Verduijn GM, de Wee EM, Rijnen Z, et al. Deep hyperthermia with the HYPERcollar system combined with irradiation for advanced head and neck carcinoma – a feasibility study. Int J Hyperthermia. 2018;34(7):994–1001.
  • Muller AC, Zips D, Heinrich V, et al. Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial. Radiat Oncol. 2015;10(1):138.
  • Schuler PJ, Westerkamp AM, Kansy BA, et al. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma. Immunobiology. 2017;222(1):66–74.
  • Jeschke MG, Rehou S, McCann MR, et al. Allogeneic mesenchymal stem cells for treatment of severe burn injury. Stem Cell Res Ther. 2019;10(1):337.
  • Liu L, Yu Y, Hou Y, et al. Human umbilical cord mesenchymal stem cells transplantation promotes cutaneous wound healing of severe burned rats. PLoS One. 2014;9(2):e88348.